JPH0597648A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0597648A JPH0597648A JP3197490A JP19749091A JPH0597648A JP H0597648 A JPH0597648 A JP H0597648A JP 3197490 A JP3197490 A JP 3197490A JP 19749091 A JP19749091 A JP 19749091A JP H0597648 A JPH0597648 A JP H0597648A
- Authority
- JP
- Japan
- Prior art keywords
- skins
- grass
- cosmetic
- raw material
- dried
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 14
- 241000196324 Embryophyta Species 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 235000004789 Rosa xanthina Nutrition 0.000 claims abstract description 3
- 241000220222 Rosaceae Species 0.000 claims abstract description 3
- 241001061264 Astragalus Species 0.000 claims description 4
- 235000006533 astragalus Nutrition 0.000 claims description 4
- 210000004233 talus Anatomy 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
- 244000025254 Cannabis sativa Species 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 8
- 230000002087 whitening effect Effects 0.000 abstract description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000012937 correction Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000008057 potassium phosphate buffer Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- -1 for example Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 206010040550 Shigella infections Diseases 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- RDXARWSSOJYNLI-UHFFFAOYSA-N [P].[K] Chemical compound [P].[K] RDXARWSSOJYNLI-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は美白作用を有し且つ皮膚
を滑らかにし、若々しい皮膚を保つ化粧品に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic product which has a whitening effect and which makes the skin smooth and keeps youthful.
【0002】[0002]
【従来の技術】キンミズヒキ属の双子葉植物網、離弁花
亜網、ばら科に属する。日本ではキンミズヒキ(Agrimon
ia eupatoria) が本州、四国、九州、琉球に自生し、山
野や道ばたにはえる多年草である。日本以外では朝鮮、
台湾、シベリア、ヒマラヤの暖帯から温帯に分布してい
る。2. Description of the Related Art It belongs to the family of dicotyledonous plants of the genus Astragalus, the subdivided flower subweb and the family Rosaceae. In Japan, Agrimony (Agrimon)
ia eupatoria) is a perennial that grows naturally in Honshu, Shikoku, Kyushu, and Ryukyu and grows in the mountains and on the roadside. Korea outside Japan,
It is distributed in the temperate to temperate zones of Taiwan, Siberia and the Himalayas.
【0003】この草は仙鶴草と称し、その全草が利用さ
れている。その目的は、止血、止瀉、消炎、強壮薬とし
て、また吐血、血便、血尿、崩漏帯下、赤白痢疾等の諸
出血症状に利用されている。しかし、化粧料としては特
開平1−313414号公報で頭部化粧料として、特開
昭60−184024号公報で殺菌性組成物として利用
されているにすぎない。This grass is called Senzuru grass, and the whole grass is used. Its purpose is to be used as a hemostasis, antidiarrheal, anti-inflammatory, tonic medicine, and for various bleeding symptoms such as hematemesis, bloody stool, hematuria, under the cleft leak zone, and Shigellosis. However, as a cosmetic, it is merely used as a head cosmetic in JP-A-1-313414 and as a bactericidal composition in JP-A-60-184024.
【0004】[0004]
【発明が解決しようとする課題】本発明の目的は、入手
が容易な原料から、皮膚に適用して安全であると共に皮
膚を滑らかにし、美白作用があり、若々しい皮膚を保つ
化粧料を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a cosmetic material which is easy to obtain, is safe to apply to the skin, smoothes the skin, has a whitening effect, and keeps youthful skin from easily available raw materials. To provide.
【0005】[0005]
【課題を解決するための手段】本発明者らは、入手が容
易である植物の抽出物を数多く試験した結果、仙鶴草が
その美白作用、皮膚老化防止作用等の点で化粧料として
非常に有効であることを見いだし本発明を完成した。す
なわち本発明は、ばら科キンミズヒキ属の全草の溶媒抽
出物を含む化粧料である。Means for Solving the Problems The inventors of the present invention have tested a large number of plant extracts that are easily available, and as a result, Senzuru-kusa is very effective as a cosmetic in terms of its whitening effect, skin anti-aging effect and the like. The present invention has been completed by finding out that it is effective. That is, the present invention is a cosmetic containing a solvent extract of the whole plant of the genus Astragalus.
【0006】キンミズヒキ属は、すでに生薬として、そ
の全草を乾燥したものが医薬品原料として販売されてい
るし、且つ日本の山野で容易に自生したものを採取でき
るのである。化粧品原料とするには、これを親水性有機
溶媒で抽出するが、一般的にはエタノール、さらにはメ
タノール、ブタノール、アセトン、またはこれらの混合
物で抽出する。これらの有機溶媒の一部を水に置き換え
ることも可能である。水の量は親水性有機溶媒の種類に
よって大きく異なるが、エタノールの場合50%以上水
を加えた溶媒で抽出すると美白成分が減少する。なお、
水のみ或いはエタノールの場合、水が50%以上でも美
白成分は減少し、このような抽出方法をとる意味がない
が、活性酸素抑制効果には影響なく、目的によってはこ
のような抽出方法もまた選択できる。[0006] The genus Astragalus has already been sold as a herbal medicine in which the whole plant is dried and used as a raw material for medicines, and it can be easily collected from the wild areas of Japan. To make a cosmetic raw material, this is extracted with a hydrophilic organic solvent, but generally, it is extracted with ethanol, further with methanol, butanol, acetone, or a mixture thereof. It is also possible to replace part of these organic solvents with water. The amount of water greatly varies depending on the type of hydrophilic organic solvent, but in the case of ethanol, whitening components decrease when extracted with a solvent containing 50% or more water. In addition,
In the case of water alone or ethanol, even if the water content is 50% or more, the whitening components are reduced, and there is no point in using such an extraction method, but there is no effect on the active oxygen suppression effect, and such an extraction method may also be used depending on the purpose. You can choose.
【0007】この抽出物を、他の化粧品原料例えばスク
ワラン、ホホバ油等の液状油、ミツロウ、セチルアルコ
ール等の固体油、各種の活性剤、グリセリン、1,3ブ
チレングリコール等の保湿剤や各種薬剤等を添加して、
さまざまな剤形の化粧料を調製することができる。例え
ばローション、クリーム、乳液、パック等で目的に応じ
て利用形態を考えればよい。This extract is used as a raw material for other cosmetics, for example, liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, moisturizing agents such as glycerin and 1,3 butylene glycol, and various drugs. Etc.,
Cosmetics of various dosage forms can be prepared. For example, a lotion, a cream, a milky lotion, a pack or the like may be used depending on the purpose.
【0008】本発明の抽出物の使用濃度としては、利用
する目的や他の配合原料によって影響を受けることは当
然であり、特に限定はないが通常0.0001〜5%で
用いるのが普通である。The concentration of the extract of the present invention to be used is naturally influenced by the purpose of use and other ingredients and is not particularly limited, but it is usually 0.0001 to 5%. is there.
【0009】[0009]
【実施例】以下に実施例により、本発明を更に具体的に
説明するが、本発明は、この実施例によって何等限定さ
れるものではない。先づ実施例、比較例で使用した抽出
物(乾燥固形物)の製造例について説明する。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. A production example of the extract (dry solid matter) used in Examples and Comparative Examples will be described first.
【0010】(製造例1)乾燥した仙鶴草20gにメタ
ノール200mlを加えて、3時間還流冷却する。これを
濾過後、凍結乾燥した。収量は1.98gであった。(Production Example 1) 200 g of methanol was added to 20 g of dried Senzuru grass and the mixture was refluxed and cooled for 3 hours. This was filtered and lyophilized. The yield was 1.98g.
【0011】(製造例2)乾燥した仙鶴草10gにエタ
ノール300mlを加えて、ソックスレー抽出器にかけて
抽出した。抽出液を凍結乾燥した。収量は1.87gで
あった。(Manufacturing Example 2) 300 g of ethanol was added to 10 g of dried Sendakusa grass and the mixture was extracted with a Soxhlet extractor. The extract was freeze-dried. The yield was 1.87g.
【0012】(実施例1) ローション (重量部) 製造例1の仙鶴草メタノール抽出物(乾燥物) 1.0 エタノール 80.0 精製水 19.0 100.0(Example 1) Lotion (parts by weight) Methanolic extract of dried cypress plant of Production Example 1 (dried product) 1.0 Ethanol 80.0 Purified water19.0 100.0
【0013】(実施例2) クリーム (重量部) A. スクワラン 20.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2の仙鶴草エタノール抽出物(乾燥物) 1.0 36.0 B. 精製水 55.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 パラオキシ安息香酸メチル 0.1 64.0 AとBとをそれぞれ計量し、70℃まで加温し、BにA
を攪拌しつつ徐々に加えたのち、ゆっくり攪拌しつつ3
0℃まで冷却した。(Example 2) Cream (parts by weight) A. Squalane 20.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2.0 Ethanol extract of dried citrus grass of Production Example 2 (dry matter)1.0 36.0 B. Purified water 55.9 Polyoxyethylene (20E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60E.O.) Hydrogenated castor oil 1.0 Glycerin 5.0 Methyl paraoxybenzoate0.1 64.0 Weigh A and B respectively, heat to 70 ° C, and add A to B
Slowly add with stirring, then slowly with stirring 3
Cooled to 0 ° C.
【0014】(比較例1)前記実施例1の抽出乾燥物を
水に替えたものを比較例1とする。(Comparative Example 1) Comparative Example 1 is obtained by replacing the dried extract of Example 1 with water.
【0015】(比較例2)前記実施例2の抽出乾燥物を
水に替えB成分としたものを比較例2とする。(Comparative Example 2) Comparative Example 2 is one in which the dried extract of Example 2 was replaced with water and used as component B.
【0016】評価方法としては、前記製造例2の抽出乾
燥物の1.0重量%エタノール溶液について、チロシナ
ーゼ活性阻害率の測定及び活性酸素抑制効果の測定及び
実施例1,2、比較例1,2のローション、クリームに
ついて、パネルによる官能検査によって評価した。As an evaluation method, a 1.0% by weight ethanol solution of the dried extract of Production Example 2 was used to measure the tyrosinase activity inhibition rate and the active oxygen suppressing effect, and Examples 1 and 2 and Comparative Examples 1 and 1 were used. The 2 lotions and creams were evaluated by a sensory test by a panel.
【0017】(チロシナーゼ活性阻害率)マックルバル
ン(Mcllvaln)緩衝液0.9ml、1.66mMチロシン(Tyr
osine)溶液1.0ml、前記製造例1又は2の抽出乾燥物
をエタノールに溶解させ、水を加えた後、エバポレータ
でエタノールを除去した後、0.1重量(乾燥物)/容
量%に調整した液(試料液)1.0mlをスクリューバイ
アルにとり、37℃恒温水槽中で5分以上加温した。チ
ロシナーゼ溶液( Sigma社製、マッシュルーム由来、9
14ユニット/ml)0.1mlを加え、37℃恒温水槽中
で保温し、10分後に475nmで吸光度を測定した。対
照として、上記試料液の替りに純水を加え、同様に測定
した。 (計算式) チロシナーゼ活性阻害率 (%)={B−(A
−P)}/B×100 但し、A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈) 結果を表1に示す。(Inhibition rate of tyrosinase activity) 0.9 ml of Mcllvaln buffer, 1.66 mM tyrosine (Tyr)
osine) solution 1.0 ml, the dried extract of Preparation Example 1 or 2 was dissolved in ethanol, water was added, and ethanol was removed by an evaporator, and then adjusted to 0.1% by weight (dry matter) / volume%. 1.0 ml of the prepared solution (sample solution) was placed in a screw vial and heated in a 37 ° C. constant temperature water tank for 5 minutes or more. Tyrosinase solution (Sigma, mushroom-derived, 9
0.1 unit (14 units / ml) was added, and the mixture was kept warm in a 37 ° C. constant temperature water bath, and after 10 minutes, the absorbance was measured at 475 nm. As a control, pure water was added instead of the above sample solution, and the same measurement was performed. (Calculation formula) Tyrosinase activity inhibition rate (%) = {B- (A
-P)} / B × 100 where A: absorbance of sample specimen B: absorbance of control P: absorbance of sample specimen due to coloration (3-fold dilution) The results are shown in Table 1.
【0018】[0018]
【表1】 [Table 1]
【0019】(活性酸素抑制濃度)大気中には21%の
酸素があり、これがないと生物(嫌気性のものを除く)
は存在しえない。しかし、酸素は紫外線や酵素等の影響
を受けて活性酸素になる。活性酸素は脂肪酸を酸化し過
酸化物を生成させる。生体の生体膜のリン脂質も酸化さ
せ、障害を与える。且つ、生成した過酸化物と活性酸素
はDNAに損傷を与え、老化を促進すると言われてい
る。また、チロシンからメラニンを作る機構にも影響を
与え皮膚の黒化にも関与している。この活性酸素を抑制
することは皮膚にとって重要な、言い換えれば化粧料に
求められる重要な要素の一つである。活性酸素を抑制す
る効果を測定する方法は各種あるが、今回以下の方法を
利用した。 pH 7.8, 50mM リン酸カリウム緩衝液(1.3mM DETAPAC含有) 133ml 40 uint/ml カタラーゼの上記のリン酸カリウム緩衝液 5ml 2mM ニトロブルーテトラゾリウムの上記のリン酸カリウム緩衝液 5ml 1.8mM キサンチンの上記のリン酸カリウム緩衝液 17ml 160ml 上記の試薬の混合物を2.4ml、前記製造例1又は2の
抽出液の凍結乾燥物をエタノールに溶解させ、水を加え
た後エバポレータでエタノールを除去した後、0.1重
量(乾燥物)/容量%に調整した液(検体)を0.3ml
加えて、キサンチンオキシダーゼ(予め検体を水とし、
実験するとき、吸光度が1分当り0.02前後上昇する
ように上記のリン酸カリウム緩衝液で調整しておく)液
を0.3ml加えて直ちに吸光度(560nm)を測定す
る。(測定は2分位し、直線性を確認する。) (計算式) 阻害率=(A−B)/A×100 A:検体を水としたときの1分当りの吸光度の変化 B:検体の1分当りの吸光度の変化 50%阻害濃度に換算した結果を表2に示す。(Active oxygen suppressing concentration) There is 21% oxygen in the atmosphere, and without this, living things (excluding anaerobic ones)
Cannot exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids and produces peroxides. It also oxidizes and damages the phospholipids of biological membranes in the body. Moreover, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. It also affects the mechanism of melanin production from tyrosine and is involved in skin darkening. Suppressing this active oxygen is one of the important factors required for the skin, in other words, for cosmetics. There are various methods for measuring the effect of suppressing active oxygen, but the following method was used this time. pH 7.8, 50mM Potassium phosphate buffer (containing 1.3mM DETAPAC) 133ml 40 uint / ml Catalase above potassium phosphate buffer 5ml 2mM Nitroblue Tetrazolium above potassium phosphate buffer 5ml 1.8mM Xanthine above phosphorus Potassium acid buffer 17 ml 160 ml 2.4 ml of the mixture of the above reagents, the lyophilized product of the extract of Preparation Example 1 or 2 was dissolved in ethanol, water was added, and the ethanol was removed by an evaporator. 0.3 ml of liquid (sample) adjusted to 1 weight (dry matter) / volume%
In addition, xanthine oxidase (use water as the sample beforehand,
At the time of experiment, 0.3 ml of the above-mentioned potassium phosphate buffer is adjusted so that the absorbance increases about 0.02 per minute) and the absorbance (560 nm) is immediately measured. (Measurement is performed for 2 minutes and linearity is confirmed.) (Calculation formula) Inhibition rate = (A−B) / A × 100 A: Change in absorbance per minute when the sample is water B: Sample Change in absorbance per minute of the results are shown in Table 2.
【0020】[0020]
【表2】 [Table 2]
【0021】(使用テスト)女性12名づつの顔面を左
右に分け、一方を実施例、もう一方を比較例として毎
日、1回以上使用してもらって、3月後、アンケートし
た。実施例、比較例それぞれ1と2を併用した。判定基
準は以下のようでアンケートの結果をまとめたのが以下
の表である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3 判定点の合計値を結果として表3に示す。(Use test) Faces of 12 women were divided into right and left sides, one of which was used as an example and the other of which was used as a comparative example once or more daily, and a questionnaire was conducted three months later. Example 1 and Comparative Example 1 were used in combination with each other. The criteria are as follows, and the results of the questionnaire are summarized in the table below. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is good −1 Comparative example is good −2 Comparative example Table 3 shows the result of the total value of -3 judgment points.
【0022】[0022]
【表3】 [Table 3]
【0023】[0023]
【発明の効果】本発明の化粧料は仙鶴草抽出物を含むこ
とによって、皮膚に対し美白作用があり、活性酸素抑制
効果があって皮膚の老化を防ぎ、小皺や肌荒を防ぎ、し
っとり感を増す効果がある。生薬として使用されてきて
いるので安全性については保証されている。EFFECTS OF THE INVENTION The cosmetic composition of the present invention has a whitening effect on the skin and has an active oxygen-suppressing effect to prevent aging of the skin, to prevent wrinkles and rough skin, and to give a moist feeling by containing the extract of Sengakurusakusa. Has the effect of increasing. Since it has been used as a crude drug, its safety is guaranteed.
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成3年12月10日[Submission date] December 10, 1991
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0018[Correction target item name] 0018
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0018】[0018]
【表1】 [Table 1]
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0020[Name of item to be corrected] 0020
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0020】[0020]
【表2】 [Table 2]
フロントページの続き (72)発明者 服部 征雄 富山県富山市五福末広町2556−4 2− 203 (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中村 雅美 三重県鳥羽市池上町6−32Front Page Continuation (72) Inventor Masao Hattori 2556-4-2 2-203 Gofuku Suehiro-cho, Toyama City, Toyama Prefecture (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture 72 Inventor Masami Nakamura Mie Prefecture 6-32 Ikegami Town, Toba City
Claims (1)
物を含む化粧料。1. A cosmetic comprising a solvent extract of the whole plant of the genus Astragalus in the family Rosaceae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3197490A JP2774882B2 (en) | 1991-07-12 | 1991-07-12 | Whitening and anti-aging cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3197490A JP2774882B2 (en) | 1991-07-12 | 1991-07-12 | Whitening and anti-aging cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0597648A true JPH0597648A (en) | 1993-04-20 |
| JP2774882B2 JP2774882B2 (en) | 1998-07-09 |
Family
ID=16375340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3197490A Expired - Fee Related JP2774882B2 (en) | 1991-07-12 | 1991-07-12 | Whitening and anti-aging cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2774882B2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
| JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
| JPH09165313A (en) * | 1995-12-15 | 1997-06-24 | Kao Corp | External preparation for skin |
| WO2010029973A1 (en) * | 2008-09-12 | 2010-03-18 | 丸善製薬株式会社 | Skin-whitening agent, anti-aging agent, and skin cosmetic |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57209208A (en) * | 1981-02-27 | 1982-12-22 | Oreal | Hair and skin treatment novel cosmetic composition |
-
1991
- 1991-07-12 JP JP3197490A patent/JP2774882B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57209208A (en) * | 1981-02-27 | 1982-12-22 | Oreal | Hair and skin treatment novel cosmetic composition |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
| JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
| JPH09165313A (en) * | 1995-12-15 | 1997-06-24 | Kao Corp | External preparation for skin |
| WO2010029973A1 (en) * | 2008-09-12 | 2010-03-18 | 丸善製薬株式会社 | Skin-whitening agent, anti-aging agent, and skin cosmetic |
| JP2010065009A (en) * | 2008-09-12 | 2010-03-25 | Maruzen Pharmaceut Co Ltd | Skin brightener and anti-aging agent, and skin cosmetic |
| US20110212041A1 (en) * | 2008-09-12 | 2011-09-01 | Keiko Tohi | Skin-Whitening Agent, Anti-Aging Agent and Skin-Care Cosmetic Agent |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2774882B2 (en) | 1998-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021147335A (en) | Nitrated protein decomposer | |
| TW201206494A (en) | Use of Tiliacora triandra in cosmetics and compositions thereof | |
| HK1245631A1 (en) | Hydroalcoholic extract of schinus molle, cosmetic compositions comprising the same and cosmetic uses thereof | |
| JP3796340B2 (en) | Serine protease inhibitor | |
| JPH1025238A (en) | Preparation for external use for skin | |
| ES2567131T3 (en) | Vanilla planifolia extract, procedure for obtaining it, and cosmetic or dermatological composition that contains it | |
| CN101198341A (en) | anti-inflammatory agent | |
| JP3235922B2 (en) | Cosmetics | |
| JP2600036B2 (en) | Cosmetics | |
| JPH0892053A (en) | External preparation for skin | |
| KR102675065B1 (en) | Cosmetic composition from Connarus semidecandrus extracts for improving atopic dermatitis | |
| JP3496967B2 (en) | Antiplasmin agent | |
| JP2774882B2 (en) | Whitening and anti-aging cosmetics | |
| JPH0687731A (en) | Cosmetic | |
| JPH05124952A (en) | Cosmetic | |
| KR100684776B1 (en) | Cosmetic composition for improving wrinkles using non-leaflet extract as an active ingredient | |
| JP3235919B2 (en) | Cosmetics | |
| JP3545057B2 (en) | Cosmetics | |
| JPH0597653A (en) | Cosmetic | |
| JP2002029923A (en) | Collagen production promoter, elastase activity inhibitor, collagen activity inhibitor and skin cosmetic | |
| JP2778855B2 (en) | Cosmetics | |
| JPH0597649A (en) | Cosmetic | |
| JPH11158054A (en) | Skin lotion | |
| JP3113009B2 (en) | Whitening cosmetics | |
| JP3547155B2 (en) | Active oxygen suppressant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |